Yohimbine-induced amygdala activation in pathological gamblers: A pilot study

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Elman, Igor ^a   Becerra, Lino ^a   Tschibelu, Evelyne ^a   Yamamoto, Rinah ^a   George, Edward ^a   Borsook, David ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIORAL STRESS; BOLD SIGNAL; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN REGION; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMPULSIVENESS; MALE; NEUROIMAGING; OPTICAL RESOLUTION; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PILOT STUDY; SENSITIZATION; STIMULUS RESPONSE; VOXEL BASED MORPHOMETRY; ADDICTION; BRAIN MAPPING; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGICAL STRESS;

ANIMALIA;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AMYGDALA; BEHAVIOR, ADDICTIVE; BRAIN MAPPING; CASE-CONTROL STUDIES; GAMBLING; HUMANS; MAGNETIC RESONANCE IMAGING; PILOT PROJECTS; STRESS, PHYSIOLOGICAL; YOHIMBINE;

EID: 84856500912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031118     Document Type: Article

References (78)

1. Potenza MN, Kosten TR, Rounsaville BJ, (2001) Pathological gambling. JAMA 286: 141-144.
2. Shaffer HJ, (1997) Pathological and problem gamblers in the United States. Pathological Gambling: A Critical Review Washington, DC National Academy Press pp. 67, 104.
3. Cunningham-Williams RM, Grucza RA, Cottler LB, Womack SB, Books SJ, et al. (2005) Prevalence and predictors of pathological gambling: results from the St. Louis personality, health and lifestyle (SLPHL) study. J Psychiatr Res 39: 377-390.
4. Grinols EL, (2004) Gambling in America: Costs and Benefits Cambridge, UK; New York Cambridge University Press.
5. DeCaria CM, Hollander E, Grossman R, Wong CM, Mosovich SA, et al. (1996) Diagnosis, neurobiology, and treatment of pathological gambling. J Clin Psychiatry 57 (Suppl 8): 80-83; discussion 83-84.
6. Potenza MN, Fiellin DA, Heninger GR, Rounsaville BJ, Mazure CM, (2002) Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med 17: 721-732.
7. Moodie C, Finnigan F, (2005) A comparison of the autonomic arousal of frequent, infrequent and non-gamblers while playing fruit machines. Addiction 100: 51-59.
8. Meyer G, Schwertfeger J, Exton MS, Janssen OE, Knapp W, et al. (2004) Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 29: 1272-1280.
9. Krueger TH, Schedlowski M, Meyer G, (2005) Cortisol and heart rate measures during casino gambling in relation to impulsivity. Neuropsychobiology 52: 206-211.
10. Meyer G, Hauffa BP, Schedlowski M, Pawlak C, Stadler MA, et al. (2000) Casino gambling increases heart rate and salivary cortisol in regular gamblers. Biol Psychiatry 48: 948-953.
11. Sharpe L, Tarrier N, Schotte D, Spence SH, (1995) The role of autonomic arousal in problem gambling. Addiction 90: 1529-1540.
12. Sharpe L, (2004) Patterns of autonomic arousal in imaginal situations of winning and losing in problem gambling. J Gambl Stud 20: 95-104.
13. Bergh C, Eklund T, Sodersten P, Nordin C, (1997) Altered dopamine function in pathological gambling. Psychol Med 27: 473-475.
14. Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, et al. (1988) Pathological gambling. A psychobiological study. Arch Gen Psychiatry 45: 369-373.
15. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W, (2004) Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28: 123-141.
16. Sodano R, Wulfert E, (2010) Cue reactivity in active pathological, abstinent pathological, and regular gamblers. J Gambl Stud 26: 53-65.
17. Biddle D, Hawthorne G, Forbes D, Coman G, (2005) Problem gambling in Australian PTSD treatment-seeking veterans. J Trauma Stress 18: 759-767.
18. Daughters SB, Lejuez CW, Strong DR, Brown RA, Breen RB, et al. (2005) The relationship among negative affect, distress tolerance, and length of gambling abstinence attempt. J Gambl Stud 21: 363-378.
19. Weinstock J, Armentano C, Petry NM, (2006) Prevalence and health correlates of gambling problems in substance abuse counselors. Am J Addict 15: 144-149.
20. Elman I, Tschibelu E, Borsook D, (2010) Psychosocial stress and its relationship to gambling urges in individuals with pathological gambling. Am J Addict 19: 332-339.
21. Heilig M, Koob GF, (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406.
22. Sinha R, (2001) How does stress increase risk of drug abuse and relapse. Psychopharmacology 158: 343-359.
23. Koob GF, (2008) A role for brain stress systems in addiction. Neuron 59: 11-34.
24. Bremner JD, Krystal JH, Southwick SM, Charney DS, (1996) Noradrenergic mechanisms in stress and anxiety: I. preclinical studies. Synapse 23: 28-38.
25. Bremner JD, Krystal JH, Southwick SM, Charney DS, (1996) Noradrenergic mechanisms in stress and anxiety: II.clinical studies. Synapse 23: 39-51.
26. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, et al. (2005) Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30: 657-668.
27. Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y, (2006) The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology 31: 2188-2196.
28. Lee B, Tiefenbacher S, Platt DM, Spealman RD, (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29: 686-693.
29. Shalev U, Erb S, Shaham Y, (2010) Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 1314: 15-28.
30. Shepard JD, Barron KW, Myers DA, (2000) Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288-295.
31. Shepard JD, Barron KW, Myers DA, (2003) Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 963: 203-213.
32. Cippitelli A, Damadzic R, Hansson AC, Singley E, Sommer WH, et al. (2010) Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology (Berl) 208: 417-426.
33. Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ, (2010) Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol 15: 491-503.
34. Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, et al. (2008) Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry 165: 390-394.
35. (2000) Diagnostic and Statistical Manual of Mental Disorders, Text Revision Washington, DC American Psychiatric Association.
36. First M, Spitzer R, Gibbon M, Williams J, Department NYBR, editor (2002) User's Guide for the SCID-I: Structured Clinical Inverview for DSM-IV-TR Axis I Disorders (Research version); New York New York State Psychiatric Institute.
37. Lesieur HR, Blume SB, (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144: 1184-1188.
38. Seymour GE, (1976) The structure and predictive ability of the Cornell Medical Index for a normal sample. J Psychosom Res 20: 469-478.
39. Neumeister A, Charney DS, Belfer I, Geraci M, Holmes C, et al. (2005) Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet Genomics 15: 143-149.
40. Stine SM, Grillon CG, Morgan CA 3rd, Kosten TR, Charney DS, et al. (2001) Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology (Berl) 154: 274-281.
41. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, et al. (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51: 642-651.
42. Southwick SM, Krystal JH, Bremner JD, Morgan CA 3rd, Nicolaou AL, et al. (1997) Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 54: 749-758.
43. Rasmusson AM, Hauger RL, Morgan CA, Bremner JD, Charney DS, et al. (2000) Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 47: 526-539.
44. Rohan M, Killgore W, Eskesen J, Renshaw P, Yurgelun-Todd D, (2001) Match-Warped EPI Anatomic Images and Amygdala: Imaging in Hard Places. Proc Intl Soc Mag Reson 9: 1237.
45. Jenkinson M, Bannister P, Brady M, Smith S, (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17: 825-841.
46. Hedner T, Edgar B, Edvinsson L, Hedner J, Persson B, et al. (1992) Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol 43: 651-656.
47. Becerra L, Harter K, Gonzalez RG, Borsook D, (2006) Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 103: 208-216, table of contents.
48. Everitt BS, Bullmore ET, (1999) Mixture model mapping of the brain activation in functional magnetic resonance images. Hum Brain Mapp 7: 1-14.
49. Pendse G, Borsook D, Becerra L, (2009) Enhanced false discovery rate using Gaussian mixture models for thresholding fMRI statistical maps. Neuroimage 47: 231-261.
50. Krystal JH, Webb E, Grillon C, Cooney N, Casal L, et al. (1997) Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP). Psychopharmacology (Berl) 131: 207-215.
51. Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, et al. (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153: 83-92.
52. Baas D, Aleman A, Kahn RS, (2004) Lateralization of amygdala activation: a systematic review of functional neuroimaging studies. Brain Res Brain Res Rev 45: 96-103.
53. Sinha R, Fox HC, Hong KI, Hansen J, Tuit K, et al. (2011) Effects of Adrenal Sensitivity, Stress- and Cue-Induced Craving, and Anxiety on Subsequent Alcohol Relapse and Treatment Outcomes. Arch Gen Psychiatry.
54. Folstein M, Folstein S, (2010) Functional expressions of the aging brain. Nutr Rev 68 (Suppl 2): S70-73.
55. Ritchey M, Bessette-Symons B, Hayes SM, Cabeza R, (2011) Emotion processing in the aging brain is modulated by semantic elaboration. Neuropsychologia 49: 640-650.
56. Roalf DR, Pruis TA, Stevens AA, Janowsky JS, (2009) More is less: Emotion induced prefrontal cortex activity habituates in aging. Neurobiol Aging.
57. Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, et al. (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36: 1178-1186.
58. de Castro V, Fong T, Rosenthal RJ, Tavares H, (2007) A comparison of craving and emotional states between pathological gamblers and alcoholics. Addict Behav 32: 1555-1564.
59. Potenza MN, (2008) Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 363: 3181-3189.
60. Tavares H, Zilberman ML, Hodgins DC, el-Guebaly N, (2005) Comparison of craving between pathological gamblers and alcoholics. Alcohol Clin Exp Res 29: 1427-1431.
61. Yamamoto RT, Karlsgodt KH, Rott D, Lukas SE, Elman I, (2007) Effects of perceived cocaine availability on subjective and objective responses to the drug. Subst Abuse Treat Prev Policy 2: 30.
62. Goeders NE, (2003) The impact of stress on addiction. Eur Neuropsychopharmacol 13: 435-441.
63. Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, et al. (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46: 1192-1204.
64. Yehuda R, Antelman SM, (1993) Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol Psychiatry 33: 479-486.
65. Belujon P, Grace AA, (2011) Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction. Ann N Y Acad Sci 1216: 114-121.
66. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N, (2005) Cue-induced brain activity in pathological gamblers. Biol Psychiatry 58: 787-795.
67. Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, et al. (2005) Imaging monetary reward in pathological gamblers. World J Biol Psychiatry 6: 113-120.
68. Angrist BM, Gershon S, (1970) The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry 2: 95-107.
69. Post RM, Uhde TW, Putnam FW, Ballenger JC, Berrettini WH, (1982) Kindling and carbamazepine in affective illness. J Nerv Ment Dis 170: 717-731.
70. Satel SL, Southwick SM, Gawin FH, (1991) Clinical features of cocaine-induced paranoia. Am J Psychiatry 148: 495-498.
71. Strakowski SM, Sax KW, Setters MJ, Keck PE Jr, (1996) Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry 40: 872-880.
72. Antelman SM, Eichler AJ, Black CA, Kocan D, (1980) Interchangeability of stress and amphetamine in sensitization. Science 207: 329-331.
73. Sorg BA, Kalivas PW, (1991) Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res 559: 29-36.
74. Chamberlain SR, Sahakian BJ, (2007) The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20: 255-261.
75. Goodman A, (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75: 266-322.
76. Tamminga CA, Nestler EJ, (2006) Pathological gambling: focusing on the addiction, not the activity. Am J Psychiatry 163: 180-181.
77. Guthrie SK, Hariharan M, Grunhaus LJ, (1990) Yohimbine bioavailability in humans. Eur J Clin Pharmacol 39: 409-411.
78. Guthrie SK, Grunhaus L, Pande AC, Hariharan M, (1993) Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic. Biol Psychiatry 34: 558-561.